INTRODUCTION
Vitiligo is an acquired skin depigmentation that affects all races but is far more disfiguring in blacks. The precise cause of vitiligo is unknown 1 . An autoimmune process targeting melanocytes is considered to mediate its pathogenesis. Consistent with this hypothesis histological studies have reported the absence of melanocytes in the affected skin 2 . In addition to cellular immunity, multiple autoantibodies against melanocyte antigens including various enzymes and other substances have been detected in the sera of some patients with vitiligo 3, 4 . Since genetic factors appear to play a role, 20% to 30% of patients were reported with a positive family history of the disorder 5, 6 .
Nevertheless, many vitiligo patients have neither a family history of vitiligo nor a history of other autoimmune diseases 6 . Consequently, many other hypotheses have been proposed to explain the pathogenesis of this disorder, including an inadequate defense from the toxic effects of free radicals and exposure of industrial chemicals 7, 8 . These effects were hypothesized to be controlled by the variable expression of cytochrome P450 (CYP or P450) genes that encode a superfamily of multi-functional monooxygenases, which comprise more than 6,000 individual enzymes 9 . CYPs play a major role in the metabolism of foreign lipophilic compounds, including drugs and chemical carcinogens, as well as endogenous compounds such as steroids, fat-soluble vitamins, fatty acids, and biogenic amines 9 . In addition, CYP expression and activity can be in uenced by various factors such as genetic variations, presence of inhibitors or inducers, and disease states with differential tissue-specific expression pattern including the skin [10] [11] [12] [13] [14] [15] . 
MATERIALS AND METHODS

Statistical analysis
Statistical analysis was performed using the statistical software program SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). Comparisons between cases and controls' genotype and allele frequencies were done using the chi-square test and odds ratio (with 95% confidence intervals). In addition, conformity to the Hardy Weinberg law of genetic equilibrium was tested among cases and controls using the chi square test through the assessment of the difference between the frequencies of the observed and the expected genotypes. A p-value ＜0.05 was considered statistically significant. 
RESULTS
Normal controls showed 5 different genotypic variants including
DISCUSSION
Cytochrome P450 2C9 has been suggested to be very similar to epoxide hydrolase (sEH), which hydrolyzes a wide variety of endogenous and exogenous epoxides that are believed to be formed by cytochrome P450 epoxygenases. Moreover, sEH was found in various tissues including the epithelial cells in the skin 20 . In active vitiligo patients, an increase in oxidative stress in the entire epidermal compartment has been demonstrated; in particular, the imbalance in catalase activity, reduced glutathione, and vitamin E levels was associated with hyperproduction of reactive oxygen species [21] [22] [23] . Oxidative DNA damage in vitiligo patients manifested by DNA breakage in mononuclear leukocytes was shown to be comparatively higher 24 . Since these factors might contribute to the susceptibility to vitiligo, we have undertaken this research to clarify the association of CYP2C9 gene polymorphism with vitiligo among Saudi patients. Frequencies of CYP2C variants among normal Saudi subjects showed a relatively unique pattern in the form of high carrier rate of *2 allele (*1/*2, *2/*3, and *2/*2 genotypes), which was 29.1% of controls that was much higher than the carriage rate for the allele *3 (*1/*3, *2/*3, and *3/*3) which was 4.7%, thus resulting into allele frequencies of 17.44% and 2.33% for alleles *2 and *3, respectively. In this respect, we would note that normal Saudi subjects had a lower carriage rate and allele frequency of CYP 2C *3 when compared to Iranians and Caucasians, whose carriage rate was as high as 5% to 10% 16, 25, 26 , but relatively closer to that of the Asian Indians, Korean, Chinese, Hispanics, and African Americans whose carriage rate was 2% to 4% [26] [27] [28] [29] [30] .
Interestingly, the Saudi vitiligo patients showed a significantly higher frequencies of *3 allele carriage rate corresponding to 32.7% of cases with a significantly higher *3 allele frequency of 16.84% but with a lower *2 allele frequency (11.05%) that was statistically insignificant compared to controls. This suggests the potential association of CYP2C9 *3 with the susceptibility to vitiligo, in this particular population. However, it is not clear whether this susceptibility is due to a primary genetic predisposition or secondary to an error related to the metabolism of certain chemicals or other environmental agents. Since CYP2C9 is an oxidative metabolizer of exogenous drugs and toxins as well as endogenous polypeptide enzymes and hormones, we can speculate that the slow metabolizing genetic form of the *3 allele predisposes the patient skin to oxidative stress probably under the effect of inhibitory drugs or toxins to the natural enzymes involved in melanin synthesis. Furthermore, the oxidative stress hypothesis is supported by the higher hydrogen peroxide levels in vitiligo epidermis that was previously attributed to factors like catalase genetic polymorphisms, reduced glutathione peroxidase activity and increased levels of tetrahydrobiopterins (6BH4 and 7BH4), which are inhibitors of tyrosinase,and phenyl alanine hydroxylase enzymes 31, 32 .
We propose an extensive analysis of all potential forms of exposure to chemicals, drugs, pollutants or radiations for all affected subjects probably using investigative techniques like HPLC. Genome wide association studies indicated that most vitiligo susceptibility loci (more than 20) encode immunoregulatory proteins or melanocyte components that likely mediate immune targeting and genetic relationships among vitiligo, malignant melanoma, and normal variation of eye, skin, and hair color 33, 34 . These loci are distributed along diverse chromosomal locations including the chromosome 10q22-23 in areas nearby the area coding the CYP2C9 (10q24). A strong association with a single nucleotide polymorphism within the major histocompatibility complex region had been also identified in a recent genome-wide association study of generalized vitiligo 35 .
Since degradation of drugs in humans is driven by detoxification mechanisms whose efficiency is influenced by genetic mutations, Weise et al. 36 studied the association between type 2 diabetes with mutations in prominent members of the CYP 450 2C9 isoenzyme family. Probable genetic contribution to the occurrence of vitiligo among Saudi subjects is relatively higher in patients with positive family history (41.1%) and consanguinity (33.7%). This study, demonstrated that consanguinity apparently had a role into the appearance of homozygous genotypes although most of them were for the normal or wild type allele *1 with some mutant forms. On the other hand, the distribution of genetic variants of CYP2C9 were not affected by age, gender, family history or pattern of vitiligo among the patients. The gene frequencies related to the CYP 2C*3 allele were in conformity with the HWE. In contrast, gene frequencies related to allele *2 were not in accordance to the HWE that might be due to higher levels of consanguinity or due to the relatively small sized sample. So, this research probably needs to be investigated in a wider study by including other interactive haplotypes and genetic polymorphisms as suggested by other scientists 37 .
Interestingly, Saudi cases did not show any significant difference from the control subjects in terms of the frequency of their CYP2C9 *2 allelic variants. Similarly, Semiz et al. 38 reported that no significant difference in allele frequencies for CYP2C9 *2, was demonstrated between diabetic and non-diabetic subjects. Recently, Kaur-Knudsen et al. 39 reported the findings of large studies on the association between genetic variation in CYP1B1 and CYP2C9 and the risk of disease, and rebutted the hypotheses that these genetic variants?influenced the risk of tobacco-related cancer, female cancer (as cervical and endometrial cancers), chronic obstructive pulmonary disease, and ischemic vascular disease. Veenstra et al. 18 found that genetic variation in CYP2C9 exons, rather than the promoter or other regulatory regions, is largely responsible for warfarin sensitivity associated with CYP2C9 variants in a European American population. Other studies have reported that CYP2C9 *3 genotype did not affect the required warfarin dose while it was associated with increased risk of bleeding when treated with routine dosage regimen during the initiation of treatment 40 .
In conclusion, this study provides presumptive evidence that CYP2C9 *3 is probably associated with the susceptibility to vitiligo among Saudi subjects regardless of the clinical pattern, gender, and presence of family history. Nonetheless, our study is limited in terms of the relatively small sample size, lack of protein studies or cell culture analyses to fully examine the underlying mechanism of vitiligo pathogenesis.
